NCT02072928 - Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence From Neurogenic Detrusor Overactivity in Belgium | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 28, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions

Urinary Incontinence

Interventions

BIOLOGICAL

botulinum toxin Type A

botulinum toxin Type A (BOTOX®) prescribed as standard of care in clinical practice.

Trial Locations (6)

UZA, Edegem

UZ Leuven, Leuven

Maria Ziekenhuis Noord-Limburg, Overpelt

CHU de Liège, Esneux

Centre Hospitalier Regional de Huy, Huy

UZ Gent, Ghent